We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.83%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$40.5B
AUM Growth
+$7.82B
(+24%)
Cap. Flow
+$9.9B
Cap. Flow
% of AUM
24.45%
Top 10 Holdings %
Top 10 Hldgs %
11.2%
Holding
4,410
New
905
Increased
1,516
Reduced
1,218
Closed
685
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$184M |
| 2 |
Dollar General
DG
|
+$152M |
| 3 |
MongoDB
MDB
|
+$129M |
| 4 |
Starbucks
SBUX
|
+$126M |
| 5 |
Costco
COST
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$111M |
| 2 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$97.7M |
| 3 |
Automatic Data Processing
ADP
|
+$90.7M |
| 4 |
Phillips 66
PSX
|
+$82.6M |
| 5 |
CVS Health
CVS
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 5.7% |
| 4 | Healthcare | 5.63% |
| 5 | Industrials | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Atea Pharmaceuticals
AVIR
$379M
| $124K | ﹤0.01% |
41,308
+22,117
| +115% | +$75.3K |
|
|
MRC
3527
DELISTED
MRC Global
MRC
| $124K | ﹤0.01% |
12,073
-52,394
| -81% | -$527K |
|
3528
Smart Sand
SND
$200M
| $122K | ﹤0.01% |
52,401
+12,938
| +33% | +$25.6K |
|
3529
Instil Bio
TIL
$48.4M
| $121K | ﹤0.01% |
14,147
+3,033
| +27% | +$30.6K |
|
|
LAZR
3530
PUT
DELISTED
Luminar Technologies
LAZR
| $120K | ﹤0.01% |
1,753
-60
| -3% | -$5.5K |
|
3531
MeiraGTx Holdings
MGTX
$1.09B
| $120K | ﹤0.01% |
+24,348
| New | +$148K |
|
3532
PetMed Express
PETS
$42.5M
| $119K | ﹤0.01% |
11,636
-7,323
| -39% | -$90.4K |
|
|
CIO
3533
DELISTED
City Office REIT
CIO
| $119K | ﹤0.01% |
+27,967
| New | +$144K |
|
3534
Byrna Technologies
BYRN
$80.3M
| $118K | ﹤0.01% |
52,540
-7,987
| -13% | -$28.5K |
|
|
MRCC
3535
DELISTED
Monroe Capital Corp
MRCC
| $117K | ﹤0.01% |
+15,740
| New | +$124K |
|
|
SCU
3536
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $117K | ﹤0.01% |
+10,052
| New | +$110K |
|
|
PGRE
3537
DELISTED
Paramount Group
PGRE
| $116K | ﹤0.01% |
+25,150
| New | +$124K |
|
3538
Aquestive Therapeutics
AQST
$462M
| $116K | ﹤0.01% |
75,683
-47,824
| -39% | -$82.2K |
|
|
WHWK
3539
Whitehawk Therapeutics
WHWK
$183M
| $114K | ﹤0.01% |
23,599
+3,656
| +18% | +$21.3K |
|
3540
SelectQuote
SLQT
$114M
| $114K | ﹤0.01% |
+97,456
| New | +$147K |
|
3541
Oportun Financial
OPRT
$257M
| $114K | ﹤0.01% |
15,769
-48,124
| -75% | -$317K |
|
|
TSP
3542
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $113K | ﹤0.01% |
+72,227
| New | +$126K |
|
3543
PUT
Clean Energy Fuels
CLNE
$447M
| $112K | ﹤0.01% |
29,300
-44,400
| -60% | -$198K |
|
3544
IAMGOLD
IAG
$8.47B
| $111K | ﹤0.01% |
51,516
-61,256
| -54% | -$151K |
|
3545
Pyxis Tankers
PXS
$45.8M
| $109K | ﹤0.01% |
29,364
-44,898
| -60% | -$162K |
|
3546
Invesco Mortgage Capital
IVR
$776M
| $108K | ﹤0.01% |
10,831
-8,417
| -44% | -$93K |
|
3547
Janux Therapeutics
JANX
$935M
| $107K | ﹤0.01% |
10,647
-17,133
| -62% | -$198K |
|
3548
OptimizeRx
OPRX
$117M
| $107K | ﹤0.01% |
13,741
-9,595
| -41% | -$104K |
|
|
PNT
3549
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $107K | ﹤0.01% |
+16,016
| New | +$133K |
|
|
KNTE
3550
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $106K | ﹤0.01% |
76,049
-72,166
| -49% | -$173K |
|
Similar funds
Squarepoint's Q3 2023 Portfolio in Review
As of Q3 2023, Squarepoint held 4,410 positions worth $40.5B, up 24% from $32.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $9.9B of net new capital in Q3 2023, opening 905 new positions and adding to 1,516 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Adobe, an estimated $111M trimmed.
- Squarepoint's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 840,063 shares worth $61.3M.
- Squarepoint added most to Tesla in Q3 2023, an estimated $184M increase.
- Squarepoint's biggest Q3 2023 reduction was Adobe, cutting an estimated $111M.
- Squarepoint fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2023, selling an estimated $56.4M.
- Squarepoint's ten largest holdings make up 11% of its $40.5B portfolio in Q3 2023.
- Squarepoint opened 905 new positions and closed 685 in Q3 2023.
- Squarepoint's portfolio value rose 24% quarter-over-quarter to $40.5B.
Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.